Neofect Co.Ltd - Asset Resilience Ratio
Neofect Co.Ltd (290660) has an Asset Resilience Ratio of 4.93% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how Neofect Co.Ltd's Asset Resilience Ratio has changed over time. Check 290660 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Neofect Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Neofect Co.Ltd market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩3.87 Billion | 4.93% |
| Total Liquid Assets | ₩3.87 Billion | 4.93% |
Asset Resilience Insights
- Limited Liquidity: Neofect Co.Ltd maintains only 4.93% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Neofect Co.Ltd Industry Peers by Asset Resilience Ratio
Compare Neofect Co.Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Bactiguard Holding AB (publ)
ST:BACTI-B |
Medical Devices | 8.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
Annual Asset Resilience Ratio for Neofect Co.Ltd (2016–2025)
The table below shows the annual Asset Resilience Ratio data for Neofect Co.Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.44% | ₩343.16 Million ≈ $232.56K |
₩77.79 Billion ≈ $52.72 Million |
-36.91pp |
| 2024-12-31 | 37.35% | ₩27.03 Billion ≈ $18.32 Million |
₩72.36 Billion ≈ $49.04 Million |
+4.46pp |
| 2023-12-31 | 32.89% | ₩23.59 Billion ≈ $15.99 Million |
₩71.71 Billion ≈ $48.60 Million |
+29.84pp |
| 2022-12-31 | 3.05% | ₩1.54 Billion ≈ $1.04 Million |
₩50.37 Billion ≈ $34.14 Million |
-8.00pp |
| 2021-12-31 | 11.05% | ₩5.80 Billion ≈ $3.93 Million |
₩52.54 Billion ≈ $35.61 Million |
-13.75pp |
| 2020-12-31 | 24.80% | ₩14.36 Billion ≈ $9.73 Million |
₩57.91 Billion ≈ $39.24 Million |
+5.47pp |
| 2019-12-31 | 19.33% | ₩9.09 Billion ≈ $6.16 Million |
₩47.02 Billion ≈ $31.86 Million |
-42.92pp |
| 2018-12-31 | 62.25% | ₩22.36 Billion ≈ $15.15 Million |
₩35.92 Billion ≈ $24.34 Million |
+23.74pp |
| 2017-12-31 | 38.51% | ₩3.93 Billion ≈ $2.66 Million |
₩10.21 Billion ≈ $6.92 Million |
-19.32pp |
| 2016-12-31 | 57.83% | ₩4.59 Billion ≈ $3.11 Million |
₩7.93 Billion ≈ $5.38 Million |
-- |
About Neofect Co.Ltd
Dynamic solution Co.,Ltd. researches, develops, manufactures, and sells rehabilitation medical devices and contents for stroke and spinal cord injuries. The company offers Neofect Smart Glove, a high-tech rehab device that measures movements of the forearm, wrist, and digits with accelerometer and bending sensors; Neofect Smart Kids for hand rehabilitation in children; Neofect Smart Board, a high… Read more